Preview

Трансплантология

Расширенный поиск

Бактериальные и грибковые инфекционные осложнения ближайшего и раннего периода трансплантации

https://doi.org/10.23873/2074-0506-2010-0-2-5-9

Полный текст:

Аннотация

В обзоре представлены данные об изменении спектра бактериальных и грибковых инфекционных осложнений раннего посттрансплантационного периода, происходящем в последнее время. Приведено обсуждение некоторых причин этого изменения. Появление полирезистентных штаммов возбудителей инфекционных осложнений требует проведения эпидемиологических исследований спектра возбудителей нозокомиальных инфекций в конкретных центрах трансплантации органов и медицинских учреждениях, в которых находятся потенциальные доноры органов. Перитрансплантационная антибиотикопрофилактика и эмпирическая антибиотикотерапия должны основываться либо на результатах таких исследований, либо на комбинированном применении антибиотиков, «перекрывающих» спектр наиболее опасных возбудителей.

Об авторе

И. А. Курмуков
ГУ РОНЦ им. Н.Н. Блохина РАМН
Россия
Илдар Анварович Курмуков


Список литературы

1. Candel F.J., Grima E., Matesanz M. et al. Bacteremia and septic shock after solid-organ transplantation. Transplant Proc 2005;37:4097–9.

2. Fishman J.A. Infection in solid-organ transplant recipients. N Engl J Med 2007;357:2601–14.

3. Danzinger-Isakov L., Kumar D.; AST infectious diseases community of practice. Guidelines for vaccination of solid organ transplant candidates and recipients. Am J Transpl 2009;9(Suppl 4):258–62.

4. Kotloff R.M., Vivek N.A., Crawford S.W. Pulmonary complications of solid organ and hematopoietic stem cell transplantation. Am J Respir Crit Care Med 2004;170:22–48; 357:2601–14.

5. National Nosocomial Infections Surveillance (NNIS). System report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004;32:470–85.

6. Parasuraman R., Samarapungavan D., Venkat K.K. Updated principles and clinical caveats in the management of infection in renal transplant recipients. Transpl Rev 2010;24:43–51.

7. Mueller N.J., Weisser M., Fehr T. et al. Donor-derived aspergillosis from use of a solid organ recipient as a multiorgan donor. Transpl Infect Dis 2010;12:54–9.

8. Sole A., Salavert M. Fungal infections after lung transplantation. Transpl Rev 2008;22:89–104.

9. Minari A., Husni R., Avery R.K. et al. The incidence of invasive aspergillosis among solid organ transplant recipients and implications for prophylaxis in lung transplants. Transpl Infect Dis 2002;4(4):195–200.

10. Neofytos D., Fishman J.A., Horn D. et al. Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients. Transpl Infect Dis 2010;12:220–9.

11. Singh N., Wagener M.M., Obman A. et al. Bacteremias in liver transplant recipients: shift toward gram-negative bacteria as predominant pathogens. Liver Transpl 2004;10:844–9.

12. Candel F.J., Grima E., Matesanz M. et al. Bacteremia and septic shock after solid-organ transplantation. Transplant Proc 2005;37:4097–9.

13. Shi S.H., Kong H.S., Xu J. et al. Multidrug resistant gram-negative bacilli as predominant bacteremic pathogens in liver transplant recipients. Transpl Infect Dis 2009;11:405–12.

14. Methicillin (oxacillin)-resistant staphylococcus aureus (MRSA) among ICU patients. Centers for Disease Control and Prevention, 1995–2004.

15. Cetinkaya Y., Falk P., Mayhall C.G. Vancomycin-resistant enterococci. Clin Microbiol Rev 2000;13:686–707.

16. Boisivon A., Thibault M., Leclercq R. et al. Colonization by vancomycin-resistant enterococci of the intestinal tract of patients in intensive care units from French general hospitals. Clin Microbiol Infect 1997;3:175–9.

17. Metallidis S., Chatzidimitriou M., Tsona A. et al. Vancomycin-resistant enterococci, colonizing the intestinal tract of patients in a university hospital in Greece. Braz J Infect Dis 2006;10:179–84.

18. Hautemaniere A., Hunter P.R., Diguio N. et al. A prospective study of the impact of colonization following hospital admission by glycopeptide-resistant Enterococci on mortality during a hospital outbreak. Am J Infect Control 2009;37:746–52.

19. Wendt C., Wiesenthal B., Dietz E., Ruden H. Survival of vancomycinresistant and vancomycin-susceptible enterococci on dry surfaces. J Clin Microbiol 1998;36:3734–6.

20. Shay D.K., Maloney S.A., Montecalvo M. et al. Epidemiology and mortality risk of vancomycin-resistant enterococcal bloodstream infections. J Infect Dis 1995;172:993–1000.

21. Cookson B.D., Macrae M.B., Barrett S.P. et al. Guidelines for the control of glycopeptide-resistant enterococci in hospitals. J Hosp Infect 2006;62:6–21.

22. Orloff S.L., Busch A.M., Olyaei A.J. et al. Vancomycin-resistant Enterococcus in liver transplant patients. Am J Surg 1999;177:418–22.

23. Mascini E.M., Jalink K.P., KampHopmans T.E. et al. Acquisition and duration of vancomycin-resistant enterococcal carriage in relation to strain type. J Clin Microbiol 2003;41:5377–83.

24. Hagen E.A., Lautenbach E., Olthoff K., Blumberg E.A. Low prevalence of colonization with vancomycin-resistant enterococcus in patients with awaiting liver transplantation. Am J Transplant 2003;3:902–5.

25. McNeil S.A., Malani P.N., Chenoweth C.E. et al. Vancomycin-resistant enterococcal colonization and infection in liver transplant candidates and recipients: a prospective surveillance study. Clin Infect Dis 2006;15:195–203.

26. Avery R., Kalaycio M., Pohlman B. et al. Early vancomycin-resistant enterococcus (VRE) bacteremia after allogeneic bone marrow transplantation is associated with a rapidly deteriorating clinical course. Bone Marrow Transpl 2005;35:497–9.

27. Dubberke E.R., Hollands J.M., Georgantopoulos P. et al. Vancomycinresistant enterococcal bloodstream infections on a hematopoietic stem cell transplant unit: are the sick getting sicker? Bone Marrow Transpl 2006;38:813–9.

28. Hogan H.L., Hachem R.Y., Neuhauser M. et al. Clinical experience of linezolid in bone marrow transplanation patients. J Pharm Pract 2010; doi:10.1177/0897190009358773.

29. Canton R., Ruiz-Garbajosa P., Chaves R.L., Johnson A.P. A potential role for daptomycin in enterococcal infections: what is the evidence? J Antimicrob Chemother 2010;65:1126–36.


Для цитирования:


Курмуков И.А. Бактериальные и грибковые инфекционные осложнения ближайшего и раннего периода трансплантации. Трансплантология. 2010;(2):5-9. https://doi.org/10.23873/2074-0506-2010-0-2-5-9

For citation:


Kurmukov I.A. Bacterial and fungal infectious complications in the immediate and early periods of transplantation. Transplantologiya. The Russian Journal of Transplantation. 2010;(2):5-9. (In Russ.) https://doi.org/10.23873/2074-0506-2010-0-2-5-9

Просмотров: 70


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 2074-0506 (Print)
ISSN 2542-0909 (Online)